Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
WNbFc 7 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 36 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 2 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 15 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
VH-Fc ab8 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 1 0
Tixagevimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/01/2021 1 0
Sunitinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 1 0
Sotrovimab Emergency use authorization Experimental Antiviral Dec/23/2021 4 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 8 0